CSF1R and neoplasm: The findings of these two studies, which employed TAMs depletion therapy in conjunction with OV therapy and immune checkpoint blockades (ICBs), yielded opposite conclusions, which could be attributed to the disparities in the virus type, CSF-1R inhibitors employed, and the tumor type.